NCT07378943
- Conditions
- Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
Clinical trial condition
Muscular Atrophy, Spinal
Explore clinical trials studying Muscular Atrophy, Spinal. Study availability and eligibility vary by location and protocol.
41 public trials
6 recruiting studies
Muscular Atrophy, Spinal trial results
NCT05156320
- Conditions
- Anti-myostatin, Atrophy, Central Nervous System Diseases, +20 more
- Locations
-
- Children's of Alabama Birmingham, Alabama, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Stanford University Medical Center Palo Alto, California, United States
NCT05481164
- Conditions
- Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
- Locations
-
- Buckinghamshire HealthCare Trust Buckingham, United Kingdom
- Dorset County Hospital (DCHFT) Dorchester, United Kingdom
- Milton Keynes University Hospital NHS Foundation Trust Milton Keynes, United Kingdom
- University of Oxford UK Oxford, United Kingdom
NCT04488133
- Conditions
- Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
- Locations
-
- Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States
- Stanford Neuromuscular Research Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
NCT04089566
- Conditions
- Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
- Locations
-
- Stanford Hospital and Clinics Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
- The Johns Hopkins Hospital Baltimore, Maryland, United States
NCT06178653
- Conditions
- Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
- Locations
-
- Medipol Mega University Hospital Istanbul, Bağcılar, Turkey (Türkiye)
Completed
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
NCT03921528
- Conditions
- Atrophy, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Stanford University Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- The Johns Hopkins University Baltimore, Maryland, United States
NCT05073133
- Conditions
- Atrophy, Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, +18 more
- Locations
-
- Novartis Investigative Site CABA, Buenos Aires, Argentina
- Novartis Investigative Site Buenos Aires, Argentina
- Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
- Novartis Investigative Site Porto Alegre, Rio Grande do Sul, Brazil
NCT02913482
- Conditions
- Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
- Locations
-
- Stanford University Medical Center Palo Alto, California, United States
- Ann and Robert H. Lurie Children Hospital of Chicago Chicago, Illinois, United States
- Boston Childrens Hospital Boston, Massachusetts, United States
- Columbia University Medical Center; The Neurological Institute of New York New York, United States
NCT05269693
- Conditions
- Central Nervous System Diseases, Child With Cancer, Child With Cerebral Palsy, +7 more
- Locations
-
- School of Nursing, The Hong Kong Polytechnic University Hong Kong, China